Page results
-
Professor Ed Wild, NHNN consultant neurologist and associate director of UCL Huntington’s Disease Centre has contributed an afterword to a new memoir by journalist Charlotte Raven, called Patient 1, Forgetting and Finding Myself.
-
Photo galleries of the PBT staff and facilities.
-
Labour leader Sir Keir Starmer, who is also the MP for our local constituency, visited UCLH on Friday 3 September and was shown around the Grafton Way Building by our chief executive and chair.
-
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.
-
After almost six months and more than 120,000 vaccinations the Islington Business Design Centre closes as a vaccination centre today (20 August 2021).
-
Stoma care nursing service at UCLH
-
Pop-up clinics in Islington will make it easier for people who are eligible for the Covid-19 vaccine – especially those who are elderly, homeless, vulnerable or in need of support – to get it closer to home.
-
UCLH Director of Research and Director of the UCLH BRC Professor Bryan Williams has received an award for outstanding contributions to research in the field of hypertension (high blood pressure).
-
Dr Hotton is a consultant neurologist with a special interest in movement disorders and the neurological care of patients with central nervous system tumours.
-
Two directors have joined the UCLH Board – Liz O’Hara, director of workforce and Laura Churchward, director of strategy.
File results
-
FOI/2019/597 In-house stop smoking service for patients
-
FOI/2019/524 UCLH Phase 5 contractors
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways
-
FOI/2019/514 Benchmarking tool
-
FOI/2019/484 Homless patients admitted to ED
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022